WORLD US FDA gives emergency use approval to GSK-Vir COVID-19 antibody drug

WORLD

US FDA gives emergency use approval to GSK-Vir COVID-19 antibody drug

Agencies

07:23, May 27, 2021

The U.S. Food and Drug Administration on Wednesday gave an emergency use authorization (EUA) to the COVID-19 antibody treatment developed by Vir Biotechnology Inc and GlaxoSmithKline.

File photo: Agencies

The EUA was for the treatment of mild-to-moderate COVID-19 in people aged 12 years and older, the US health regulator said. (https://bit.ly/3uorQZ8)

Sotrovimab, the antibody treatment, is not authorized for patients who are hospitalized due to COVID-19 or require oxygen therapy, according to the agency.

The European Union's drug regulator last week backed the use of the drug for patients who are at risk of severe disease and do not need supplemental oxygen.

Terms of Service & Privacy Policy

We have updated our privacy policy to comply with the latest laws and regulations. The updated policy explains the mechanism of how we collect and treat your personal data. You can learn more about the rights you have by reading our terms of service. Please read them carefully. By clicking AGREE, you indicate that you have read and agreed to our privacy policies

Agree and continue